utility

header_second

RegMed Investors (RMi) went exclusive on July 27th!

Your complimentary subscription to RegMed Investors’ (RMi) reporting on the stem, cell and gene therapy and RegMed sector has expired.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

It’s up to you to choose the level of content access to provide a premium experience and value - don’t wait to exhale!

I also bring fresh perspectives that yield a whole that is greater than the sum of the parts as I convey a spectrum of factors that explain outcomes, analytical principles and analysis without the encumbrance of trading, investment or I-Banking.

So, after these years of following our facts … first and fast; be part of our “inner circle” as a subscriber!

Stay with me and join our coalition and have a seat at the appreciation table!

Login Sign up now Not now

content_top

34 companies, 1 interpreter! Insight, foresight
and recommendation

Closing Bell

content_middle

Closing Bell

content_right

June 30, 2025 - 4:36pm | Closing Bell
RegMed Investors (RMi) Closing Bell: the sword hung by a single horsehair, implying an ever-present peril facing share pricing

OTCQB: HRGN
June 27, 2025 - 4:58pm | Closing Bell
RegMed Investors (RMi) Closing Bell: Econ’s inflation data was hotter than expected as May PCE pushes rate cuts odds lower

OTCQB: HRGN
June 26, 2025 - 4:53pm | Closing Bell
RegMed Investors (RMi) Closing Bell: Econs cried havoc and let slip the algo dogs of electronic trading

OTCQB: HRGN
June 25, 2025 - 4:36pm | Closing Bell
RegMed Investors (RMi) Closing Bell: Electronic trading slipped in to minimize earlier share pricing blast circumference

OTCQB: HRGN
June 24, 2025 - 4:44pm | Closing Bell
RegMed Investors (RMi) Closing Bell: clicking on the after burners

OTCQB: HRGN
June 23, 2025 - 4:33pm | Closing Bell
RegMed Investors (RMi) Closing Bell: Sector has minor collateral damage

OTCQB: HRGN
June 20, 2025 - 4:43pm | Closing Bell
RegMed Investors (RMi) Closing Bell: Luckily, the canopy opened

OTCQB: HRGN
June 18, 2025 - 4:55pm | Closing Bell
RegMed Investors (RMi) Closing Bell: a sector of flash bang pricing movements

OTCQB: HRGN
June 17, 2025 - 4:55pm | Closing Bell
RegMed Investors (RMi) Closing Bell: I love the smell of gene therapy sentiment in the morning!!

VERV, LLY, BMY, EDIT, NTLA, BEAM, CRSP, BNTX, CVAC, SAGE, SUPN
June 16, 2025 - 4:41pm | Closing Bell
RegMed Investors (RMi) Closing Bell: My view/words ring true

OTCQB: HRGN
June 13, 2025 - 6:29pm | Closing Bell
RegMed Investors (RMi) Closing Bell: sector bottoms evident as collateral damage

OTCQB: HRGN
June 12, 2025 - 4:48pm | Closing Bell
RegMed Investors (RMi) Closing Bell: Present value in the cell and gene therapy share pricing reflects the sector’s acrobatics

OTCQB: HRGN
June 11, 2025 - 5:00pm | Closing Bell
RegMed Investors (RMi) Closing Bell: inflationary econ was soft, thumping markets and tripping sector

OTCQB: HRGN
June 10, 2025 - 4:54pm | Closing Bell
RegMed Investors (RMi) Closing Bell: got it up

OTCQB: HRGN
June 9, 2025 - 5:19pm | Closing Bell
RegMed Investors (RMi) Closing Bell: sector momentum waned

OTCQB: HRGN
June 6, 2025 - 5:06pm | Closing Bell
RegMed Investors (RMi) Closing Bell: surprise, a positive open and close

OTCQB: HRGN
June 5, 2025 - 5:46pm | Closing Bell
RegMed Investors (RMi) Closing Bell: Signs of hesitancy in share pricing activity

OTCQB: HRGN
June 4, 2025 - 4:48pm | Closing Bell
RegMed Investors (RMi) Closing Bell: Gauging sector breadth

OTCQB: HRGN
June 3, 2025 - 4:32pm | Closing Bell
RegMed Investors (RMi) Closing Bell: who and what is driving gains

AGEN, BEAM, MRNA, BMY, SAN, CRSP, VCEL
June 2, 2025 - 4:44pm | Closing Bell
RegMed Investors (RMi) Closing Bell: sector thrives on acquisition, partner and regulatory news

BNTX, BPMC, BMY, SAN, MRNA

Pages

footer

© 2015 RegMed Investors (regmedinvestors.com), all rights are reserved.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry MCusker . Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of RegMed Investors (RM-i); who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other RM-i media services or reposting please email hwm@regmedinvestors.com.